We are live on
!
Find out more
MCP
Martin Capital Partners Portfolio holdings
AUM
$272M
1-Year Est. Return
19.09%
This Fund
S&P 500
This Quarter
Est. Return
+5.55%
1 Year Est. Return
+19.09%
3 Year Est. Return
+35.19%
5 Year Est. Return
+47.96%
10 Year Est. Return
–
AUM
$169M
AUM Growth
+$20.6M
(+14%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
7.52%
Top 10 Holdings %
Top 10 Hldgs %
32.59%
Holding
63
New
10
Increased
44
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$2.93M |
| 2 |
Merck
MRK
|
+$2.43M |
| 3 |
Gilead Sciences
GILD
|
+$1.68M |
| 4 |
ExxonMobil
XOM
|
+$1.51M |
| 5 |
MSC Industrial Direct
MSM
|
+$1.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBK
Westpac Banking Corporation
WBK
|
+$2.82M |
| 2 |
GSK
GSK
|
+$2.07M |
| 3 |
Apple
AAPL
|
+$1.54M |
| 4 |
AT&T
T
|
+$1.46M |
| 5 |
Microsoft
MSFT
|
+$525K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.23% |
| 2 | Financials | 16.38% |
| 3 | Technology | 12.35% |
| 4 | Consumer Staples | 11.19% |
| 5 | Energy | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
State Street SPDR S&P Dividend ETF
SDY
$23.5B
| $303K | 0.18% |
2,815
+251
| +10% | +$26.3K |
|
52
Cullen/Frost Bankers
CFR
$10.4B
| $287K | 0.17% |
+2,932
| New | +$272K |
|
53
CenterPoint Energy
CNP
$27.6B
| $284K | 0.17% |
10,406
+3,648
| +54% | +$99.2K |
|
|
MPT
54
Medical Properties Trust
MPT
$2.74B
| $267K | 0.16% |
+12,670
| New | +$256K |
|
|
ISBC
55
DELISTED
Investors Bancorp, Inc.
ISBC
| $264K | 0.16% |
22,192
+7,154
| +48% | +$85.7K |
|
56
Ingredion
INGR
$6.28B
| $244K | 0.14% |
+2,630
| New | +$221K |
|
57
Vanguard International Dividend Appreciation ETF
VIGI
$9.08B
| $230K | 0.14% |
+3,188
| New | +$221K |
|
58
Unum
UNM
$14.3B
| $219K | 0.13% |
+7,521
| New | +$219K |
|
59
Cracker Barrel
CBRL
$1.32B
| $213K | 0.13% |
+1,383
| New | +$218K |
|
60
Paychex
PAYX
$42B
| $201K | 0.12% |
+2,362
| New | +$199K |
|
61
Hope Bancorp
HOPE
$1.81B
| $163K | 0.1% |
+10,952
| New | +$159K |
|
|
AWF
62
AllianceBernstein Global High Income Fund
AWF
$874M
| $161K | 0.1% |
13,241
| – | – |
|
|
WBK
63
DELISTED
Westpac Banking Corporation
WBK
| – | – |
-141,231
| Closed | -$2.82M |
|
Similar funds
SC
SC
TP
S
SCM
FCMV
MAM
MLM
Martin Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Martin Capital Partners held 63 positions worth $169M, up 14% from $149M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Martin Capital Partners deployed $12.7M of net new capital in Q4 2019, opening 10 new positions and adding to 44 existing holdings. Its largest new stake was Kellanova: 48,411 shares worth $3.14M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was GSK, an estimated $2.07M trimmed.
- Martin Capital Partners's largest Q4 2019 buy was Kellanova: 48,411 shares worth $3.14M.
- Martin Capital Partners added most to Gilead Sciences in Q4 2019, an estimated $1.68M increase.
- Martin Capital Partners's biggest Q4 2019 reduction was GSK, cutting an estimated $2.07M.
- Martin Capital Partners fully exited Westpac Banking Corporation in Q4 2019, selling an estimated $2.82M.
- Martin Capital Partners's ten largest holdings make up 33% of its $169M portfolio in Q4 2019.
- Martin Capital Partners opened 10 new positions and closed 1 in Q4 2019.
- Martin Capital Partners's portfolio value rose 14% quarter-over-quarter to $169M.
Based on Martin Capital Partners's 13F filing for Q4 2019, filed 31 Jan 2020.